![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 21, 2023 9:49:12 AM
Pluri is at the forefront of this extraordinary new world.
Our state-of-the-art, proprietary bioreactor system – developed over many years during our work in regenerative medicine –
provides a 3D micro-environment for cells, resembling their natural environment.
Our advanced manufacturing technology is tightly controlled, completely automated, efficient and scalable. It can generate
high-quality cell products on a mass scale with batch-to-batch consistency, whether these cells derive from humans, plants or
animals. Our cell expansion platforms are emerging as the new gold standard to accelerate creation of cell-based solutions.
https://pluri-biotech.com/wp-content/uploads/2023/09/Pluri-Report-2023-final.pdf
![Bullish](/static/images/ih2-bull.png)
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM